News & Articles - Rhodiola Rosea

Siberian Rhodiola rosea "Is Not An MAO Inhibitor"

Siberian Rhodiola rosea is not an MAO inhibitor, such as St. Johns Wort or any of the pharmaceutical MAO inhibiting drugs currently on the market. MAO inhibitors differ from Siberian Rhodiola rosea in that they actually stop the manufacture of serotonin, of which only 2% to 3% is found in the rahe nucleus of the brain. Just a little difference in that small area can make a big difference in how we act, think and react.

Siberian Rhodiola rosea, being an Adaptogen, does not inhibit, but balances monoamine oxidase and aldehyde dehydrogenase, which are the two enzymes responsible for limiting the production of serotonin in the brain. That may seem like a small point, but actually is a major one. If inhibited, serotonin can drop below normal for any given individual leading them to a substantial deviation in personality and ultimately lead them to physician care.

Another reason I bring this to your attention is that clinical research and antidotal experience suggests that mixing some natural MAO inhibitors, such as St. Johns Wort with pharmaceuticals MAO inhibiting drugs, can become dangerous. Our experience with Rosavin over the past 6 years along with the more than 1000 Psychiatrists and patients taking it, (many of which are on other pharmaceutical MAO inhibitors), has not produced any evidence of contraindication.

This response was written because of confusion concerning true MAO inhibitors and Rosavin, which is a proprietarily processed Siberian Rhodiola rosea. If you need further information or would like to read more about Siberian Rhodiola rosea and its benefits pick up the book Arctic Root from your nearest book store or call us at 1-888-405-3336 to order your copy direct.

Best Regards,
Richard L. Hall, CEO

If you have any questions please contact us at info@ameriden.com.

This information is intended for informational and educational purposes only and is not intended to diagnose, cure or prevent any disease. The Food & Drug Administration has not evaluated the statements within.